Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas

Pancreatology

Volumn 2, Issue 6, 2002, Pages 510-518

  Standop, Jens ^a,c   Ulrich, Alexis B ^a,c   Schneider, Matthias B ^a   Büchler, Markus W ^d   Pour, Parviz M ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chronic pancreatitis; Islets of Langerhans; Pancreatic cancer; Pancreatic polypeptide; Xenobiotic metabolizing enzymes

Indexed keywords

ANTIBODY; CYTOCHROME P450; ENZYME; ISOENZYME; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; XENOBIOTIC AGENT; GLUTATHIONE TRANSFERASE; PANCREAS POLYPEPTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; CARCINOMA; CHILD; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME METABOLISM; ENZYME SPECIFICITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; PANCREAS; PRIMORDIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; COMPARATIVE STUDY; ENZYMOLOGY; INFANT; METABOLISM; MIDDLE AGED; PANCREAS ISLET; PRESCHOOL CHILD; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; ISLETS OF LANGERHANS; ISOENZYMES; MALE; MIDDLE AGED; PANCREAS; PANCREATIC POLYPEPTIDE; TISSUE DISTRIBUTION; XENOBIOTICS;

EID: 0036436763     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000066093     Document Type: Article

References (47)

1. Büchler MW, Uhl W, Malfertheiner P: Pankreaserkrankungen: Akute Pankreatitis, Chronische Pankreatitis, Tumore des Pankreas. Basel, Karger, 1996.
2. Pedrazzoli S, Beger HG, Obertop H, Andren-Sandberg A, Fernandez-Cruz L, Henne-Bruns D, Luttges J, Neoptolemos JP: A surgical and pathological based classification of resective treatment of pancreatic cancer: Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg 1999;16:337-345.
3. Beger HG, Schlosser W, Siech M, Poch B: The surgical management of chronic pancreatitis: Duodenum-preserving pancreatectomy. Adv Surg 1999;32:87-104.
4. Braganza JM: Pancreatic disease: A casualty of hepatic 'detoxification'? Lancet 1983;ii:1000-1003.
5. Braganza JM: A framework for the aetiogenesis of chronic pancreatitis. Digestion 1998;59(suppl 4):1-12.
6. Standop J, Schneider MB, Ulrich A, Pour PM: Experimental animal models in pancreatic carcinogenesis: Lessons for human pancreatic cancer. Dig Dis 2001;19:24-31.
7. Tolbert PE: Oils and cancer. Cancer Causes Control 1997;8:386-405.
8. Pour PM: Experimental pancreatic cancer. Am J Surg Pathol 1989;13(suppl 1):96-103.
9. Pour P, Donnelly T: Effect of cholecystoduodenostomy and choledochostomy in pancreatic carcinogenesis. Cancer Res 1978;38:2048-2051.
10. Wallig MA: Xenobiotic metabolism, oxidant stress and chronic pancreatitis: Focus on glutathione. Digestion 1998;59(suppl 4):13-24.
11. Ulrich AB, Schmied BM, Matsuzaki H, Lawson TA, Friess H, Andren-Sandberg A, Büchler MW, Pour PM: Increased expression of glutathione S-transferase-pi in the islets of patients with primary chronic pancreatitis but not secondary chronic pancreatitis. Pancreas 2001;22:388-394.
12. Boyer TD: The glutathione S-transferases: An update. Hepatology 1989;9:486-496.
13. Lewis DF, Ioannides C, Parke DV: Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen. Environ Health Perspect 1998;106:633-641.
14. Foster JR, Idle JR, Hardwick JP, Bars R, Scott P, Braganza JM: Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol 1993;169:457-463.
15. Ulrich A, Schmied B, Standop J, Schneider M, Lawson T, Friess H, Andren-Sandberg A, Büchler M, Pour P: Differences in the expression of glutathione S-transferases in normal pancreas, chronic pancreatitis, secondary chronic pancreatitis and pancreatic cancer. Pancreas 2002;24:291-297.
16. Martella EM, Ferraro G, Azzoni C, Marignani M, Bordi C: Pancreatic-polypeptide cell hyperplasia associated with pancreatic or duodenal gastrinomas. Hum Pathol 1997;28:149-153.
17. Peters J, Jurgensen A, Kloppel G: Ontogeny, differentiation and growth of the endocrine pancreas. Virchows Arch 2000;436:527-538.
18. Wacke R, Kirchner A, Prall F, Nizze H, Schmidt W, Fischer U, Nitschke FP, Adam U, Fritz P, Belloc C, Drewelow B: Up-regulation of cytochrome P450 1A2, 2C9, and 2E1 in chronic pancreatitis. Pancreas 1998;16:521-528.
19. Pour PM, Kazakoff K, Dulany K: A new technique for simultaneous demonstration of 4 tumor-associated antigens in pancreatic cancer cells. Zentralbl Pathol 1994;140:397-401.
20. Ferner H: Das Inselorgan des Pankreas. Stutt-gart, Thieme, 1952.
21. Chester-Jones I, Ingelton P, Phillips G (eds): Fundamentals of Comparative Vertebrate Endocrinology. New York, Plenum Publishing Corporation, 1986.
22. Adrian T, Bloom S, Bryant MG: Distribution and release of human pancreatic polypeptide. Gut 1976;17:940-944.
23. Lonovics J, Devitt P, Watson LC, Rayford PL, Thompson JC: Pancreatic polypeptide: A review. Arch Surg 1981;116:1256-1264.
24. Rahier J, Wallon J, Loozen S, Lefevre A, Gepts W, Haot J: The pancreatic polypeptide cells in the human pancreas: The effects of age and diabetes. J Clin Endocrinol Metab 1983;56:441-444.
25. Hazelwood R: The pancreatic polypeptide (PP-fold) family: Gastrointestinal, vascular, and feeding behavioral implications. Proc Soc Exp Biol Med 1993;202:44-63.
26. Murakami T, Hitomi S, Ohtsuka A, Taguchi T, Fujita T: Pancreatic insulo-acinar portal systems in humans, rats, and some other mammals: Scanning electron microscopy of vascular casts. Microsc Res Tech 1997;37:478-488.
27. Murray GI: The role of cytochrome P450 in tumour development and progression and its potential in therapy. J Pathol 2000;192:419-426.
28. Kaminsky LS, Spivack SD: Cytochromes P450 and cancer. Mol Aspects Med 1999;20:70-84.
29. Hirvonen A: Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect 1999;107(suppl 1):37-47.
30. Ketterer B: Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 1988;202:343-361.
31. Jakoby WB: The glutathione S-transferases: A group of multifunctional detoxification proteins. Adv Enzymol Relat Areas Mol Biol 1978;46:383-414.
32. Hayes JD, Pulford DJ: The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
33. Hasler JA: Pharmacogenetics of cytochromes P450. Mol Aspects Med 1999;20:12-24, 25-137.
34. Crespi CL, Penman BW, Gelboin HV, Gonzalez FJ: A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 1991;12:1197-1201.
35. Rendic S, Di Carlo FJ: Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 1997;29:413-580.
36. Guengerich FP, Shimada T, Yun CH, Yamazaki H, Raney KD, Thier R, Coles B, Harris TM: Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes. Environ Health Perspect 1994;102(suppl 9):49-53.
37. Shimada T, Iwasaki M, Martin MV, Guengerich FP: Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. Cancer Res 1989;49:3218-3228.
38. Guengerich FP: Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem Biol Interact 1997;106:161-182.
39. Kazakoff K, Iversen P, Lawson T, Baron J, Guengerich FP, Pour PM: Involvement of cytochrome P450 2E1-like isoform in the activation of N-nitrosobis(2-oxopropyl)amine in the rat nasal mucosa. Eur J Cancer B Oral Oncol 1994;30B:179-185.
40. Muscat J, Stellman S, Hoffmann D, Wynder E: Smoking and pancreatic cancer in men and women. Cancer Epidemiol Biomarkers Prev 1997;6:15-19.
41. Chen SC, Wang X, Zhou L, Kolar C, Lawson TA, Mirvish S: Metabolism of the hamster pancreatic carcinogen methyl-2-oxopropylnitrosamine by hamster liver and pancreas. Int J Pancreatol 2000;27:105-112.
42. Issenberg P, Conrad EE, Nielsen JW, Klein DA, Miller SE: Determination of N-nitrosobis(2-hydroxypropyl)amine in environmental samples. IARC Sci Publ 1984;57:43-50.
43. Herrera PL, Huarte J, Sanvito F, Meda P, Orci L, Vassalli JD: Embryogenesis of the murine endocrine pancreas: Early expression of pancreatic polypeptide gene. Development 1991;113:1257-1265.
44. Lukinius A, Ericsson JL, Grimelius L, Korsgren O: Ultrastructural studies of the ontogeny of fetal human and porcine endocrine pancreas, with special reference to colocalization of the four major islet hormones. Dev Biol 1992;153:376-385.
45. Slack JM: Developmental biology of the pancreas. Development 1995;121:1569-1580.
46. Bocian-Sobkowska J, Zabel M, Wozniak W, Surdyk-Zasada J: Prenatal development of the human pancreatic islets. Immunocytochemical identification of insulin-, glucagon-, somato-statin- and pancreatic polypeptide-containing cells. Folia Histochem Cytobiol 1997;35:151-154.
47. Masters B: Introduction: Cytochrome P450. FASEB J 1997;10:205.